Journal of the American Chemical Society · 2009 · 100 citations · 66 references
PharmacyMedicinal ChemistryMicrobiologyDrug DiscoveryNatural Product BiosynthesisSynthetic Medicinal ChemistryAntibiotic ResistanceAntibiotic Resistance MechanismsMicrobial Natural Product BiosynthesisNatural Product Drug DiscoveryAntibiotic DiscoveryBacterial Natural Product BiosynthesisHeterocyclic Natural ProductsLipid ElongationNatural Product SynthesisNovel Antibacterial Drug DiscoverySecondary MetabolitesVancomycin-intermediate Resistance
The secondary metabolites platensimycin and platencin, isolated from the bacterial strain Streptomyces platensis, represent a novel class of natural products exhibiting unique and potent antibacterial activity. Platencin, though structurally similar to platensimycin, has been found to operate through a slightly different mechanism of action involving the dual inhibition of lipid elongation enzymes FabF and FabH. Both natural products exhibit strong, broad-spectrum, gram-positive antibacterial activity to key antibiotic resistant strains, including methicillin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, and vancomycin-resistant Enterococcus faecium. Described herein are our synthetic efforts toward platencin, culminating in both racemic and asymmetric preparation of the natural product. The syntheses demonstrate the power of the cobalt-catalyzed asymmetric Diels-Alder reaction and the one-pot reductive rearrangement of [3.2.1] bicyclic ketones to [2.2.2] bicyclic olefins.
66
Oxidation of α,β-un saturated aldehydes
Balkrishna S. Bal, Wayne E. Childers, Harold W. Pinnick · Tetrahedron · 1981 · 1.1K citations